Studies have shown that the Na+-glucose cotransporter 1 (SGLT1/SLC5A1) transporter and KATP channel-regulated GLP-1 secretion is significantly impaired in T2D patients. Here, SLC5A1 is linked to type 2 diabetes mellitus.